Home > Products > API > Vecuronium bromide
Vecuronium bromide
  • Vecuronium bromideVecuronium bromide

Vecuronium bromide

Product Name:Vecuronium bromide
Formulae hypotheticae: C34H57BrN2O4
Molecular pondus: 637,73138
CAS Subcriptio Number: 50700-72-6

Model:CAS NO:50700-72-6

Mitte Inquisitionem

depictio producti

Vecuronium bromide

Product nomen:Vecuronium bromide 50700-72-6
CAS No:50700-72-6
Specification: in domo

Nomen Vecuronium bromide
Synonyma norcuron; -2-(1-piperidyl)-2,3,4,5,6; 7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetate;1-[(2Beta,3alpha,5alpha,16beta,17beta)-3 ,17-bisChemic albook(acetyloxy)-2-(1-piperidinyl) androstan-16-yl] -1-methylpiperidiniumbromidehydratorum; 1-(3-alpha, 17-beta-diacetoxy-2-beta-piperidino -5-alpha-androstan-piperidiniu;17beta-diol,16beta-pipecolinio-2beta-piperidino-5alpha-androstan-3alphbro;medio,diacetato;nc-45;orgnc45;
copyRight
M CAS # 59-02-9, Vitamin E, D-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
Formulae hypotheticae C34H57BrN2O4
M. Pondus 637.73138
CAS Subcriptio Number 50700-72-6


Pertractatio et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum



Hot Tags: Vecuronium bromide, China, Suppliers, Manufacturers, Factory
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept